SOURCE: Implant Sciences

Implant Sciences

May 24, 2011 07:00 ET

Implant Sciences Receives $329,000 in Orders From China and Middle East

Recent Sales Show the Strength of the Company's Products and Distribution Channels

WILMINGTON, MA--(Marketwire - May 24, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced two orders totaling $329,000 from China and Saudi Arabia for its Quantum Sniffer™ QS-H150 portable explosives trace detection (ETD) device. The QS-H150 units will be deployed for law enforcement in China and force protection in Saudi Arabia.

With these orders, Implant Sciences has announced a total of approximately $2.9 million in new orders since May 17th. For the nine month period ended March 31, 2011, the Company reported a total of $4,885,000 in revenues, representing a 76% increase over the comparable prior year period.

"Our international distribution partners have been very successful at getting the QS-H150 into the hands of security forces that need the most efficient and effective portable ETD on the market today," stated Bruce Bower, Implant Sciences' Sr. Vice President, Sales and Marketing. "The recent launch of the QS-B220 provides them with another tool for helping our customers fulfill their security needs."

Implant Sciences' CEO, Glenn D. Bolduc, commented, "We are working toward continued and consistent growth in international revenues, while aiming to establish our presence in the U.S. homeland security market. We are very encouraged by the response our recently formed government sales and marketing team received to our products from key federal, state, and local security product decision makers at FPED VIII."

About the Quantum Sniffer QS-H150

The QS-H150 Quantum Sniffer is a hand-held explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability and extremely low total cost of ownership.

About the Quantum Sniffer QS-B220

The QS-B220 Quantum Sniffer, introduced in May 2011, is a bench-top explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, or homemade explosives and narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact